Рациональная фармакотерапия гиперкинетических расстройств
Copyright policy )Рациональная фармакотерапия гиперкинетических расстройств
The data concerning hyperkinetic disorder syndrome are shortly reviewed in the paper. Principal attention is focused on the analysis of effects of metabolic activators (atomoxetine), neuroleptics (thioridazine, chlorprotixene) and different antidepressants (fluoxetine, fluvoxamine, sertraline, tianeptine, pipophesine).
Краткий обзор данных по гиперкинетическим расстройствам. Клинико-фармакологический анализ эффектов активатора метаболизма (атомоксетин); нейролептиков (тиоридазин, хлорпротиксен) и антидепрессантов разных групп (флюоксетин, флувоксамин, сертралин, тианептин, пипофезин).
ГИПЕРКИНЕТИЧЕСКОЕ РАССТРОЙСТВО,ЛЕКАРСТВЕННОЕ ЛЕЧЕНИЕ,HYPERKINETIC DISORDER,DRUG THERAPY
ГИПЕРКИНЕТИЧЕСКОЕ РАССТРОЙСТВО,ЛЕКАРСТВЕННОЕ ЛЕЧЕНИЕ,HYPERKINETIC DISORDER,DRUG THERAPY
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!